Diminished ovarian reserve Clinical Trials

9 recruitingLast updated: May 13, 2026

There are 9 actively recruiting diminished ovarian reserve clinical trials across 3 countries. Studies span Not Applicable, Phase 1, Phase 2, Phase 3. Top locations include Beijing, Beijing Municipality, China, Beijing, China, Hangzhou, Zhejiang, China. Updated daily from ClinicalTrials.gov.


Diminished ovarian reserve Trials at a Glance

9 actively recruiting trials for diminished ovarian reserve are listed on ClinicalTrialsFinder across 6 cities in 3 countries. The largest study group is Not Applicable with 5 trials, with the heaviest enrollment activity in Beijing, Beijing, and Hangzhou. Lead sponsors running diminished ovarian reserve studies include Peking University Third Hospital, Jiangxi University of Traditional Chinese Medicine, and Hangzhou TCM Hospital Affiliated to Zhejiang Chinese Medical University.

Browse diminished ovarian reserve trials by phase

Treatments under study

About Diminished ovarian reserve Clinical Trials

Looking for clinical trials for Diminished ovarian reserve? There are currently 8 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Diminished ovarian reserve trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Diminished ovarian reserve clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 19 of 9 trials

Recruiting
Phase 1Phase 2

Bushen Yiqi Formula Combined With Dehydroepiandrosterone in Women With Diminished Ovarian Reserve

Diminished ovarian reserve
Jiangxi University of Traditional Chinese Medicine74 enrolled1 locationNCT07535983
Recruiting
Phase 3

Clinical and Metabolomics Studies on the Improvement of Ovarian Reserve by Acupoint Photodynamic Therapy and Traditional Chinese Medicine Treatment

Diminished Ovarian Reserve (DOR)
Peking Union Medical College Hospital90 enrolled1 locationNCT07376824
Recruiting
Not Applicable

DPOS Versus GnRH Antagonist Protocol for Oocyte Accumulation in Low Ovarian Reserve Patients: An RCT

Diminished ovarian reserve
Tam Anh TP. Ho Chi Minh General Hospital730 enrolled2 locationsNCT05847283
Recruiting
Not Applicable

A Randomized Controlled Study on the Effect of MRJPs on Improving Ovarian Function and Endometrial Receptivity

Diminished Ovarian Reserve (DOR)Thin Endometrium
The Fourth Affiliated Hospital of Zhejiang University School of Medicine66 enrolled1 locationNCT07246733
Recruiting

Characterization of Gut and Tongue Coating Microbiota in Patients With Diminished Ovarian Reserve

Diminished ovarian reserve
Hangzhou TCM Hospital Affiliated to Zhejiang Chinese Medical University200 enrolled1 locationNCT07124260
Recruiting
Not Applicable

The Effect of VitC on IVF Outcome of DOR Patients

Diminished ovarian reserveIVF Outcomes
Peking University Third Hospital1,100 enrolled6 locationsNCT06794047
Recruiting
Not Applicable

Ovarian PRP for Diminished Ovarian Reserve

Diminished ovarian reserve
Generation Next Fertility230 enrolled1 locationNCT05790655
Recruiting

The Correlation Between Ovarian Function and Serum Biomarkers

Diminished ovarian reserveAgingPremature Ovarian Insufficiency+3 more
Shi Yun35 enrolled1 locationNCT06096766
Recruiting
Not Applicable

The Effeciency of NMN in Improving IVF/ICSI-ET Pregnancy Outcomes in Patients With DOR

Diminished ovarian reserve
Peking University Third Hospital200 enrolled1 locationNCT06426355